Drugs / HCP1201
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02026817 | Dec 2013 | diabetes mellitus | Hanmi Pharmaceutical Company Limited | Completed | No outcome recorded |
| Phase 1 | NCT02011633 | Oct → Nov 2013 | diabetes mellitus | Hanmi Pharmaceutical Company Limited | Completed | No outcome recorded |
| Phase 1 | NCT01901757 | Jun → Jul 2013 | diabetes mellitus | Hanmi Pharmaceutical Company Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HCP1201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02011633 ↗ |
| Route | Oral | “single oral dose of HCP1201 under fasted condition” NCT01901757 ↗ |